Clinical studies have shown that weight loss with tirzepatide typically continues as long as the medication is used, with the most significant results often seen within the first 12 to 18 months
A RDBPCT (MOZART study) showed that ezetimibe 10 mg orally daily for 24 weeks did not significantly affect hepatic steatosis over placebo [52]
Other Information: Contains no added milk, egg, peanut, tree nut, fish, shellfish, soy, wheat, or yeast ingredients., MADE FROM RECYCLED MATERIALS
Secondary outcomes included percentage of time with sensor glucose in ranges of interest (70-180 mg/dL - Time in Range, below 70mg/dL -Time Below Range, and greater than 180 mg/dL - Time Above Range) Results Summary A1C decreased by a mean of 0.8%, from 8.2% at baseline to 7.4% at the end of the 13-week treatment phase
Im always completely happy with my results